<DOC>
	<DOC>NCT02545049</DOC>
	<brief_summary>The purpose of this study is to evaluate whether oral finerenone (study drug), in addition to standard daily therapy, is effective and safe in treating patients with type 2 diabetes mellitus and diabetic kidney disease, when compared to a placebo.</brief_summary>
	<brief_title>Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<criteria>Men or women ≥18 years of age Subjects with Type Type 2 Diabetes Mellitus as defined by the American Diabetes Association Diagnosis of Diabetic Kidney Disease with persistent high albuminuria or persistent very high albuminuria at the RunIn and Screening Visit Pretreated with either angiotensinconverting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) at maximal tolerated labeled dose without adjustments Serum potassium &lt;=4.8 mmol/L Confirmed significant nondiabetic renal disease, including clinically relevant renal artery stenosis Uncontrolled arterial hypertension (ie, mean sitting systolic blood pressure (SBP) ≥170 mmHg or mean sitting diastolic blood pressure(DBP) ≥110 mmHg at run in visit, or mean sitting SBP ≥160 mmHg or mean sitting DBP ≥100 mmHg at screening) Clinical diagnosis of chronic heart failure with reduced ejection fraction (HFrEF) and persistent symptoms {New York Heart Association (NYHA) class II IV} at Run in visit [class 1A recommendation for mineralcorticoid receptor antagonist (MRAs)] Dialysis for acute renal failure within 12 weeks of Runin visit Renal allograft in place or scheduled kidney transplant within next 12 months Glycated hemoglobin (HbA1c) &gt;12%.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Type 2 Diabetes</keyword>
	<keyword>Kidney diseases</keyword>
</DOC>